IC-KDA + ASAD 2025. International Conference of the Korean Dementia Assocition 2025 & 19th International Congress of the Asian Society Against Dementia. May 8th - 10th, 2025. Lotte Hotel World, Seoul, Korea.

Daily Program

검색
* Please choose 1 of 3 options [Session, Name, Title].
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
08:20-09:15
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies (Room A+B)

Room A
Chairperson Seol-Heui Han (Konkuk University, Korea)
Atsushi Iwata (Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan)
Lecanemab Maintenance Dosing in Early Alzheimer's Disease: Support for Continued Dosing from Clinical, Pharmacology and Modeling Data

Larisa Reyderman (Eisai)

Donanemab TRAILBLAZER-ALZ 2 Long-term Extension Data: Latest Findings and Clinical Implications

Saygin Gonderten (Eli Lilly and Company, UAE)

Update on Trontinemab, A Novel Brainshuttle Antibody in Development for the Treatment of Alzheimer’s Disease

Tobias Bittner (F.Hoffmann-LaRoche, Switzerland)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
09:15-09:45
Opening Ceremony (Room A+B)

Room A
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
09:45-10:25
Plenary Session 1 (Room A+B)

Room A
Chairperson Jae-Hong Lee (University of Ulsan, Korea)
The Latest in Alzheimer’s and Dementia Science: A New Era of Research, Treatment and Care

Maria C. Carrillo (Alzheimer's Association, USA)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
10:55-12:15
Plenary Session 2 (Room A+B)

Room A
Chairperson Seong Hye Choi (Inha University, Korea)
Christopher Chen Li-Hsian (National University of Singapore, Singapore)
The History of Immunotherapy in Alzheimer’s Disease

SangYun Kim (Seoul National University, Korea)

Experience of Anti-amyloid β Antibody Therapies for Alzheimer's Disease in Japan

Ken Nagata (Yokohama General Hospital, Japan)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
12:15-12:45
Lunch Symposium 1 (Room A+B)

Room A
Chairperson Hae Ri Na (Bobath Memorial Hospital, Korea)

Hyemin Jang (Seoul National University, Korea)

Sung Hoon Kang (Korea Universty, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
12:15-12:45
Lunch Symposium 2

Room C
Chairperson Byoungseok Ye (Yonsei University, Korea)
Developing 2nd Generation PDE5 Inhibitor for the Treatment of Alzheimer’s Disease

Jai-Jun Choung (AriBio Co. Ltd, Korea)

The Benefits of Combination Treatment in Alzheimer’s Disease

Bon D. Ku (Catholic Kwandong University, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
12:45-13:30
Assembly of the Korean Dementia Association (In Korean) (Room A+B)

Room A
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
12:45-14:00
Poster Session

Hall
Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
14:00-15:00
Parallel Symposium 1

Prospective Cohort Studies of Subjective Cognitive Decline

Room A
Chairperson Seong Yoon Kim (University of Ulsan, Korea)
Vincent C.T. MOK (The Chinese University of Hong Kong, China)
Something to Offer for Patients with SCD: The Concept of Brain Health Services

Frank Jessen (University Hospital of Cologne, Germany)

Biomarker Changes in Subjective Cognitive Decline Subjects - COSCO Study Results

Dong Won Yang (The Catholic University of Korea, Korea)

Association of Retinal Markers with Cognitive Impairment in the TIGER Cohort

Yen-Ching Chen (National Taiwan University, Taiwan)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
14:00-15:00
Parallel Symposium 2

Molecular Mechanisms and Multi-omics Approaches in Neurodegenerative Diseases

Room B
Chairperson Young Ho Park (Seoul National University, Korea)
Wei-Ju Lee (Taichung Veterans General Hospital, Taiwan)
Molecular Mechanisms and Genetic Risk Factors in Alzheimer’s Disease: Advances and Challenges

Thomas Wingo (University of California, USA)

Beyond Genotypes: Metabolomics and Epigenomics as Emerging Frontiers in Alzheimer’s Disease Research

Jun Pyo Kim (Sungkyunkwan University, Korea)

Transcriptional Risk in Alzheimer’s Disease

Jung-Min Pyun (Soonchunhyang University, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
14:00-15:00
Oral Presentation

Room C
Chairperson Chan-Nyoung Lee (Korea University, Korea)
Yeonsil Moon (Konkuk University, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
15:30-16:30
Parallel Symposium 3

Stress and Resilience for Cognition

Room A
Chairperson Juhee Chin (Hallym University, Korea)
Chronic Environmental Stress (Storm and Flooding) and Cognitive Impairment

Jacqueline Dominguez (St. Luke's Medical Center, Philippines)

Cognitive Reserve and Alzheimer’s Disease: Clinical Implication

Yeshin Kim (Kangwon National University, Korea)

Neuroimaging Approach to Capture Cognitive Reserve

Yong Jeong (KAIST, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
15:30-16:30
Parallel Symposium 4

Emerging Targets for Precision Medicine Against Alzheimer’s Disease

Room B
Chairperson Jee Hoon Roh (Korea Universty, Korea)
Han Kyoung Choe (DGIST, Korea)
Neuron-Glia Communication in Lewy Body Dementia

Tae-In Kam (KAIST, Korea)

Presenilin 2 N141I Mutation and Hyperactive Immune Response

Seong-Woon Yu (DGIST, Korea)

Innovative Gene and Cell Therapies for Alzheimer’s Disease

Hanseul Park (Chungbuk National University, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
15:30-16:30
Oral Presentation

Room C
Chairperson JungSeok Lee (Jeju National University, Korea)
Hanna Cho (Yonsei University, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
16:30-17:30
Parallel Symposium 5

Lifestyle Intervention for Dementia Prevention

Room A
Chairperson Seung-Ho Ryu (Konkuk University, Korea)
Chaur-Jong Hu (Taipei Medical University, Shuang Ho Hospital, Taiwan)
Blood Biomarkers for the Early Preclinical Diagnosis of Alzheimer’s Disease

Ralph Martins (Alzheimer’s Research Australia, Edith Cowan University, Macquarie University, Australia)

Community Based Interventions for Mental and Cognitive Health in Older Adults

Linda Chiu Wa Lam (The Chinese University of Hong Kong, Hong Kong SAR(China))

SUPERBRAIN: K-Finger study A Multidomain Intervention for Dementia Prevention and Cognitive Enhancement

Jee Hyang Jeong (Ewha Womans University, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
16:30-17:30
Parallel Symposium 6

Young Onset Dementia Asia Pacific Research

Room B
Chairperson Ingmar Skoog (University of Gothenburg, Sweden)
Yuan-Han Yang (Kaohsiung Medical University, Taiwan)
Young Onset Dementia Asia Pacific Research Collaborative (YOD-APC)

Samantha Loi (Royal Melbourne Hospital, University of Melbourne, Australia)

Early Onset Dementia: Experience from Thailand

Vorapun Senanarong (Mahidol University, Thailand)

Longitudinal Study of Early Onset Dementia and Family Members (LEAF)

Eun Joo Kim (Pusan National University, Korea)

Updates, Treating Alzheimer's Disease with Monoclonal Antibodies
May 9 (Fri)
16:30-17:30
Parallel Symposium 7

Normal Pressure Hydrocephalus in the Elderly

Room C
Chairperson Mee Young Park (Yeungnam University, Korea)
Young Noh (Gachon University, Korea)
Promoting Clinical Practice and Research in Idiopathic Normal-Pressure Hydrocephalus

Etsuro Mori (Osaka University, Japan)

Innovations in Diagnosing Idiopathic Normal Pressure Hydrocephalus: Deep Learning Approaches to Imaging and Gait Impairment Analysis

Shigeki Yamada (Nagoya City University, Japan)

Alzheimer’s Disease and Idiopathic Normal Pressure Hydrocephalus: Clinical and Research Perspectives

Kyunghun Kang (Kyungpook National University, Korea)

Organized by 대한치매학회 Asian Society Against Dementia
Supported by Korea Tourism Organization SEOUL METROPOLITAN GOVERNMENT Seoul Tourism Organization